{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:49:08Z","timestamp":1752551348971},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00277-016-2832-6","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T22:26:53Z","timestamp":1476743213000},"page":"9-16","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed\/refractory Hodgkin\u2019s lymphoma in patients older than 50\u00a0years"],"prefix":"10.1007","volume":"96","author":[{"name":"on behalf of Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gayoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonzalez-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Revilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sampol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Domingo-Domenech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Rodriguez-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Valiente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"P\u00e9rez-Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P\u00e9rez","family":"de Oteyza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"2832_CR1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood-2010-08-302604","volume":"119","author":"J Sj\u00f6berg","year":"2012","unstructured":"Sj\u00f6berg J, Halthur C, Kristinsson SY, Landgren O, Nygell UA, Dickman PW, Bj\u00f6rkholm M (2012) Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973\u20132009. Blood 119:990\u2013996","journal-title":"Blood"},{"key":"2832_CR2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood-2011-09-378414","volume":"119","author":"AM Evens","year":"2012","unstructured":"Evens AM, Helenowski I, Ramsdale E, Nabhan C, Karmali R, Hanson B, Parsons B, Smith S, Larsen A, McKoy JM, Jovanovic B, Gregory S, Gordon LI, Smith SM (2012) A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era. Blood 119:692\u2013695","journal-title":"Blood"},{"key":"2832_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11899-011-0089-7","volume":"6","author":"TV Halbsguth","year":"2011","unstructured":"Halbsguth TV, B\u00f6ll B, Borchmann P, Diehl V (2011) The unique characteristics and management of patients over 60\u00a0years of age with classic Hodgkin lymphoma. Curr Hematol Malig Rep 6:164\u2013171","journal-title":"Curr Hematol Malig Rep"},{"key":"2832_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ajh.21910","volume":"86","author":"A Carbone","year":"2011","unstructured":"Carbone A, Spina M, Gloghini A, Tirelli U (2011) Classical Hodgkin\u2019s lymphoma arising in different host\u2019s conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol 86:170\u2013179","journal-title":"Am J Hematol"},{"key":"2832_CR5","first-page":"438","volume":"88","author":"O Landgren","year":"2003","unstructured":"Landgren O, Algernon C, Axdorph U, Nilsson B, Wedelin C, Porwit-MacDonald A, Grimfors G, Bj\u00f6rkholm M (2003) Hodgkin\u2019s lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematol 88:438\u2013444","journal-title":"Haematol"},{"key":"2832_CR6","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1182\/blood-2011-12-396556","volume":"119","author":"SJ Proctor","year":"2012","unstructured":"Proctor SJ, Wilkinson J, Jones G, Watson GC, Lucraft HH, Mainou-Fowler T, Culligan D, Galloway MJ, Wood KM, McNally RJ, James PW, Goodlad JR (2012) Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60\u00a0years or over: the SHIELD study. Blood 119:6005\u20136015","journal-title":"Blood"},{"key":"2832_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejca.2005.01.010","volume":"41","author":"DJ Spronsen van","year":"2005","unstructured":"van Spronsen DJ, Janssen-Heijnen ML, Lemmens VE, Peters WG, Coebergh JW (2005) Independent prognostic effect of co-morbitity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 41:1051\u20131057","journal-title":"Eur J Cancer"},{"key":"2832_CR8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"DC Linch","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A, Chopra R, Milligan D, Hudson GV (1993) Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin\u2019s disease: results of a BNLI randomised trial. Lancet 341:1051\u20131054","journal-title":"Lancet"},{"key":"2832_CR9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, M\u00fcller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin\u2019s disease: a randomised trial. Lancet 359:2065\u20132071","journal-title":"Lancet"},{"key":"2832_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"2832_CR11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245\u20131251","journal-title":"J Clin Epidemiol"},{"key":"2832_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2014.09.010","volume":"68","author":"Y Marko","year":"2015","unstructured":"Marko Y, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D (2015) A systematic review identifies valid comorbidity indices derived from administrative health data. J Clin Epidemiol 68:3\u201314","journal-title":"J Clin Epidemiol"},{"key":"2832_CR13","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912\u20132119","journal-title":"Blood"},{"key":"2832_CR14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","volume":"19","author":"A Sureda","year":"2001","unstructured":"Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, Garc\u00eda-Conde J, Jarque I, Caballero MD, Ferr\u00e0 C, L\u00f3pez A, Garc\u00eda-Lara\u00f1a J, Cabrera R, Carrera D, Ruiz-Romero MD, Le\u00f3n A, Rif\u00f3n J, D\u00edaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Alt\u00e9s A, L\u00f3pez-Guillermo A, de la Serna J, Fern\u00e1ndez-Ra\u00f1ada JM, Sierra J, Conde E (2001) Autologous stem-cell transplantation for Hodgkin\u2019s disease: results and prognostic factors in 494 patients from the Grupo Espa\u00f1ol de Linfomas\/Transplante Aut\u00f3logo de M\u00e9dula \u00d3sea Spanish Cooperative Group. J Clin Oncol 19:1395\u20131404","journal-title":"J Clin Oncol"},{"key":"2832_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1702796","volume":"27","author":"HM Lazarus","year":"2001","unstructured":"Lazarus HM, Loberiza FR Jr, Zhang M-J, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM (2001) Autotransplants for Hodgkin\u2019s disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant 27:387\u2013396","journal-title":"Bone Marrow Transplant"},{"key":"2832_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.294","volume":"46","author":"N Puig","year":"2011","unstructured":"Puig N, Pintilie M, Seshadri T, Al-Farsi K, Franke N, Keating A, Kuruvilla J, Crump M (2011) High-dose chemotherapy and ASCT in elderly patients with Hodgkin\u2019s lymphoma. Bone Marrow Transplant 46:1\u20136","journal-title":"Bone Marrow Transplant"},{"key":"2832_CR17","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1182\/blood.V122.21.3408.3408","volume":"122","author":"H Glick","year":"2013","unstructured":"Glick H, Lee C, Sauter CS, Moskowitz CH, Matasar MJ (2013) Autologous stem cell transplant is a feasible treatment for older relapsed and refractory Hodgkin lymphoma patients. Blood 122:3408","journal-title":"Blood"},{"key":"2832_CR18","first-page":"616","volume":"110","author":"M Sorror","year":"2007","unstructured":"Sorror M, Storer B, Gopal A, Holmberg L, Sandmaier BM, Bensinger WI, Maloney DG, Press OW, Storb RF (2007) Comorbidity, lactate dehydrogenase (LDH), and chemosensitivity are independent predictors of mortality after autologous hematopoietic cell transplantation (HCT) for patients (pts) with lymphoma. ASH Annu Meet Abstr 110:616","journal-title":"ASH Annu Meet Abstr"},{"key":"2832_CR19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/bmt.2010.188","volume":"46","author":"WJ Plattel","year":"2011","unstructured":"Plattel WJ, Kluin-Nelemans HC, de Bock GH, van Imhoff GW (2011) Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant 46:827\u2013834","journal-title":"Bone Marrow Transplant"},{"key":"2832_CR20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/annonc\/mdm608","volume":"19","author":"C Hosing","year":"2008","unstructured":"Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T, De Padua SL, Kebriaei P, Alousi A, De Lima M, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I (2008) High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin\u2019s lymphoma in patients >65\u00a0years of age. Ann Oncol 19:1166\u20131171","journal-title":"Ann Oncol"},{"key":"2832_CR21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbmt.2008.05.002","volume":"14","author":"TM Wildes","year":"2008","unstructured":"Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, Dipersio JF, Devine SM (2008) Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 14:840\u2013846","journal-title":"Biol Blood Marrow Transplant"},{"key":"2832_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbmt.2008.06.019","volume":"14","author":"L Labont\u00e9","year":"2008","unstructured":"Labont\u00e9 L, Iqbal T, Zaidi MA, McDiarmid SA, Huebsch LB, Tay J, Atkins H, Allan DS (2008) Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 14:1039\u20131044","journal-title":"Biol Blood Marrow Transplant"},{"key":"2832_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbmt.2013.12.557","volume":"20","author":"A Saad","year":"2014","unstructured":"Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN (2014) Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Biol Blood Marrow Transplant 20:402\u2013408","journal-title":"Biol Blood Marrow Transplant"},{"key":"2832_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bjh.13561","volume":"171","author":"SH Gohil","year":"2015","unstructured":"Gohil SH, Ardeshna KM, Lambert JM, Pule MA, Mohamedbhai S, Virchis A (2015) Autologous stem cell transplantation outcomes in elderly patients with B cell non-Hodgkin lymphoma. Br J Haematol 171:197\u2013204","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2832-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T14:34:25Z","timestamp":1601130865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2832-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}